JoVE 비디오를 활용하시려면 도서관을 통한 기관 구독이 필요합니다.  전체 비디오를 보시려면 로그인하거나 무료 트라이얼을 시작하세요.
A Viral Attachment Assay for Screening of Antiviral Compounds

A Viral Attachment Assay for Screening of Antiviral Compounds

내레이션 대본

Begin with a multi-well plate containing a pre-chilled human hepatoma cell monolayer.

Treat test wells with a mix of genetically modified hepatitis C virus carrying the luciferase gene and a target compound; treat control wells with the virus alone.

In the test wells, target molecules interact with viral glycoproteins and cell surface receptors, preventing viral attachment.

However, in control wells, viral glycoproteins interact with cell surface receptors, enabling their attachment. A low temperature inhibits viral entry.

Remove the supernatant, introduce a medium, and re-incubate at the optimum temperature, facilitating viral entry.

Upon entry, the virus releases the genetic material, initiating the synthesis of viral proteins and luciferase enzymes, which are secreted into the medium.

Transfer the luciferase-containing supernatant, and introduce a substrate.

The enzyme-substrate interaction produces light in proportion to luciferase levels.

The lower light intensity in the test wells, compared to the control wells, indicates the antiviral property of the target compound.

Related Videos

Read Article